Form 4: Orchestra BioMed Holdings Director Reports Stock Transaction
Insider Transaction (Form 4)
John Prosper Mack, a Director of Orchestra BioMed Holdings, Inc., reported a transaction in 4,885 shares of common stock on August 12, 2026.
Summary
- Tax/exercise-price withholding: disposed of 4,885 Common Stock, par value $0.0001 per share at $4.42 ($21,592) on August 12, 2026; holds 66,544 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John Prosper Mack — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-12 | Tax/exercise-price withholding | Common Stock, par value $0.0001 per share | 4,885 | $4 | $21.6K | 66,544 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-12 | Tax/exercise-price withholding (4,885 shares) |
Keywords
insider transaction, Form 4, OBIO, Orchestra BioMed Holdings, Inc., neutral, John Prosper Mack
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.